Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hansen

Showing results (1451-1460 of 1,581) with videos related to

Pageof 159
Sort By:
Emerging Infectious Diseases|February 7, 2008
Spectrum of infection and risk factors for human monkeypox, United States, 2003Mary G Reynolds, Whitni B Davidson, Aaron T Curns, et al.
Current Oncology (Toronto, Ont.)|May 3, 2019
Real-world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database ConsortiumI Stukalin, J C Wells, J Graham, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2017
Discovery of potent and selective inhibitors of calmodulin-dependent kinase II (CaMKII)Dmitry O Koltun, Eric Q Parkhill, Rao Kalla, et al.
Journal of Geriatric Oncology|March 6, 2021
Efficacy of immune-checkpoint inhibitors (ICI) in the treatment of older adults with metastatic renal cell carcinoma (mRCC) - an International mRCC Database Consortium (IMDC) analysisDaniel V Araujo, J Connor Wells, Aaron R Hansen, et al.
Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Cochlear implants with dexamethasone-eluting electrode arrays reduce foreign body response in a murine model of cochlear implantation and human subjectsMuhammad Taifur Rahman, Brian Mostaert, Peter Eckard, et al.
Frontiers in Oncology|January 22, 2025
Initial clinical experience with [<sup>177</sup>Lu]Lu-PNT2002 radioligand therapy in metastatic castration-resistant prostate cancer: dosimetry, safety, and efficacy from the lead-in cohort of the SPLASH trialAaron R Hansen, Stephan Probst, Jean-Mathieu Beauregard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2024
Targeting CCL2/CCR2 Signaling Overcomes MEK Inhibitor Resistance in Acute Myeloid LeukemiaRucha V Modak, Katia G de Oliveira Rebola, John McClatchy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2023
Neoadjuvant Cabazitaxel plus Abiraterone/Leuprolide Acetate in Patients with High-Risk Prostate Cancer: ACDC-RP Phase II TrialNeil E Fleshner, Rashid K Sayyid, Aaron R Hansen, et al.
Journal for Immunotherapy of Cancer|June 15, 2022
Increase in serum choline levels predicts for improved progression-free survival (PFS) in patients with advanced cancers receiving pembrolizumabGeoffrey Alan Watson, Enrique Sanz-Garcia, Wen-Jiang Zhang, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2019
The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trialGeorg A Bjarnason, Jennifer J Knox, Christian K Kollmannsberger, et al.
Pageof 159

Showing results (1451-1460 of 1,581) with videos related to

Sort By:
Pageof 159
Emerging Infectious Diseases|February 7, 2008
Spectrum of infection and risk factors for human monkeypox, United States, 2003Mary G Reynolds, Whitni B Davidson, Aaron T Curns, et al.
Current Oncology (Toronto, Ont.)|May 3, 2019
Real-world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database ConsortiumI Stukalin, J C Wells, J Graham, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2017
Discovery of potent and selective inhibitors of calmodulin-dependent kinase II (CaMKII)Dmitry O Koltun, Eric Q Parkhill, Rao Kalla, et al.
Journal of Geriatric Oncology|March 6, 2021
Efficacy of immune-checkpoint inhibitors (ICI) in the treatment of older adults with metastatic renal cell carcinoma (mRCC) - an International mRCC Database Consortium (IMDC) analysisDaniel V Araujo, J Connor Wells, Aaron R Hansen, et al.
Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Cochlear implants with dexamethasone-eluting electrode arrays reduce foreign body response in a murine model of cochlear implantation and human subjectsMuhammad Taifur Rahman, Brian Mostaert, Peter Eckard, et al.
Frontiers in Oncology|January 22, 2025
Initial clinical experience with [<sup>177</sup>Lu]Lu-PNT2002 radioligand therapy in metastatic castration-resistant prostate cancer: dosimetry, safety, and efficacy from the lead-in cohort of the SPLASH trialAaron R Hansen, Stephan Probst, Jean-Mathieu Beauregard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2024
Targeting CCL2/CCR2 Signaling Overcomes MEK Inhibitor Resistance in Acute Myeloid LeukemiaRucha V Modak, Katia G de Oliveira Rebola, John McClatchy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2023
Neoadjuvant Cabazitaxel plus Abiraterone/Leuprolide Acetate in Patients with High-Risk Prostate Cancer: ACDC-RP Phase II TrialNeil E Fleshner, Rashid K Sayyid, Aaron R Hansen, et al.
Journal for Immunotherapy of Cancer|June 15, 2022
Increase in serum choline levels predicts for improved progression-free survival (PFS) in patients with advanced cancers receiving pembrolizumabGeoffrey Alan Watson, Enrique Sanz-Garcia, Wen-Jiang Zhang, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2019
The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trialGeorg A Bjarnason, Jennifer J Knox, Christian K Kollmannsberger, et al.
Pageof 159